{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:26:27Z","timestamp":1791926787220,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T00:00:00Z","timestamp":1132185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T00:00:00Z","timestamp":1132185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.jhh.1001948","type":"journal-article","created":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T10:27:21Z","timestamp":1132223241000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia"],"prefix":"10.1038","volume":"20","author":[{"given":"J S","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G H","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Jeunemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P N","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P R","family":"Conlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,17]]},"reference":[{"key":"BF1001948_CR1","first-page":"661","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW . Primary aldosteronism. J Lab Clin Med 1955; 45: 661\u2013664.","journal-title":"J Lab Clin Med"},{"key":"BF1001948_CR2","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1210\/jc.2003-030490","volume":"88","author":"JS Williams","year":"2003","unstructured":"Williams JS, Williams GH . 50th anniversary of aldosterone. J Clin Endocrinol Metab 2003; 88: 2364\u20132372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.HYP.5.1.116","volume":"5","author":"D McAreavey","year":"1983","unstructured":"McAreavey D, Murray GD, Lever AF, Robertson JI . Similarity of idiopathic aldosteronism and essential hypertension. A statistical comparison. Hypertension 1983; 5: 116\u2013121.","journal-title":"Hypertension"},{"key":"BF1001948_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0140-6736(01)05509-X","volume":"358","author":"R Fraser","year":"2001","unstructured":"Fraser R, Lever AF, Brown JJ, Robertson JI . Cautions over idiopathic aldosteronism. Lancet 2001; 358: 332.","journal-title":"Lancet"},{"key":"BF1001948_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(00)04223-9","volume":"357","author":"NM Kaplan","year":"2001","unstructured":"Kaplan NM . Cautions over the current epidemic of primary aldosteronism. Lancet 2001; 357: 953\u2013954.","journal-title":"Lancet"},{"key":"BF1001948_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.jhh.1001319","volume":"16","author":"JM Connell","year":"2002","unstructured":"Connell JM . Is there an epidemic of primary aldosteronism? J Hum Hypertens 2002; 16: 151\u2013152.","journal-title":"J Hum Hypertens"},{"key":"BF1001948_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.jhh.1001321","volume":"16","author":"PL Padfield","year":"2002","unstructured":"Padfield PL . Primary aldosteronism, a common entity? the myth persists. J Hum Hypertens 2002; 16: 159\u2013162.","journal-title":"J Hum Hypertens"},{"key":"BF1001948_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa033263","volume":"351","author":"JC Vasan RS, Evans","year":"2004","unstructured":"Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 33\u201341.","journal-title":"N Engl J Med"},{"key":"BF1001948_CR9","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1001\/archinte.1991.00400090078014","volume":"151","author":"M Yakovlevitch","year":"1991","unstructured":"Yakovlevitch M, Black HR . Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151: 1786\u20131792.","journal-title":"Arch Intern Med"},{"key":"BF1001948_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0889-8529(18)30033-1","volume":"24","author":"WR Litchfield","year":"1995","unstructured":"Litchfield WR, Dluhy RG . Primary aldosteronism. Endocrinol Metab Clin North Am 1995; 24: 593\u2013612.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF1001948_CR11","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1210\/jcem.86.8.9995","volume":"86","author":"A Ganguly","year":"2001","unstructured":"Ganguly A . Prevalence of primary aldosteronism in unselected hypertensive populations: screening and definitive diagnosis. J Clin Endocrinol Metab 2001; 86: 4002\u20134004.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD . Primary aldosteronism \u2013 careful investigation is essential and rewarding. Mol Cell Endocrinol 2004; 217: 33\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"BF1001948_CR13","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"Young Jr WF . Minireview: primary aldosteronism \u2013 changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 2208\u20132213.","journal-title":"Endocrinology"},{"key":"BF1001948_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC . High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF1001948_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","volume":"20","author":"RD Gordon","year":"1993","unstructured":"Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA . Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993; 20: 296\u2013298.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF1001948_CR16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981; 141: 1589\u20131593.","journal-title":"Arch Intern Med"},{"key":"BF1001948_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","volume":"67","author":"DH Streeten","year":"1979","unstructured":"Streeten DH, Tomycz N, Anderson GH . Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403\u2013413.","journal-title":"Am J Med"},{"key":"BF1001948_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045\u20131050.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40: 897\u2013902.","journal-title":"Hypertension"},{"key":"BF1001948_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"Schwartz GL, Turner ST . Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386\u2013394.","journal-title":"Clin Chem"},{"key":"BF1001948_CR21","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR22","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF . Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854\u20132859.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00004872-200103000-00002","volume":"19","author":"M Stowasser","year":"2001","unstructured":"Stowasser M . Primary aldosteronism: revival of a syndrome. J Hypertens 2001; 19: 363\u2013366.","journal-title":"J Hypertens"},{"key":"BF1001948_CR24","first-page":"383","volume":"86","author":"C Hambling","year":"1993","unstructured":"Hambling C, Jung RT, Browning MC, Gunn A, Anderson JM . Primary hyperaldosteronism \u2013 evaluation of procedures for diagnosis and localization. Q J Med 1993; 86: 383\u2013392.","journal-title":"Q J Med"},{"key":"BF1001948_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1536\/ihj.26.549","volume":"26","author":"S Naomi","year":"1985","unstructured":"Naomi S, Iwaska T, Umeda T, Inoue J, Hamasaki S, Miura F et al. Clinical evaluation of the captopril screening test for primary aldosteronism. Jpn Heart J 1985; 26: 549\u2013556.","journal-title":"Jpn Heart J"},{"key":"BF1001948_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/0002-9343(86)90291-3","volume":"81","author":"NK Hollenberg","year":"1986","unstructured":"Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH . Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med 1986; 81: 412\u2013418.","journal-title":"Am J Med"},{"key":"BF1001948_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03349761","volume":"18","author":"RD Gordon","year":"1995","unstructured":"Gordon RD . Primary aldosteronism. J Endocrinol Invest 1995; 18: 495\u2013511.","journal-title":"J Endocrinol Invest"},{"key":"BF1001948_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00004872-200101000-00013","volume":"19","author":"A Raji","year":"2001","unstructured":"Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK et al. Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001; 19: 99\u2013105.","journal-title":"J Hypertens"},{"key":"BF1001948_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004872-199602000-00008","volume":"14","author":"PN Hopkins","year":"1996","unstructured":"Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14: 199\u2013207.","journal-title":"J Hypertens"},{"key":"BF1001948_CR30","first-page":"632","volume":"81","author":"RL Emanuel","year":"1973","unstructured":"Emanuel RL, Cain JP, Williams GH . Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973; 81: 632\u2013640.","journal-title":"J Lab Clin Med"},{"key":"BF1001948_CR31","first-page":"848","volume":"79","author":"RH Underwood","year":"1972","unstructured":"Underwood RH, Williams GH . The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med 1972; 79: 848\u2013862.","journal-title":"J Lab Clin Med"},{"key":"BF1001948_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P . Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40: 892\u2013896.","journal-title":"Hypertension"},{"key":"BF1001948_CR33","first-page":"1066","volume":"86","author":"SB Magill","year":"2001","unstructured":"Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001; 86: 1066\u20131071.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001948_CR34","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A Ganguly","year":"1998","unstructured":"Ganguly A . Primary aldosteronism. N Engl J Med 1998; 339: 1828\u20131834.","journal-title":"N Engl J Med"},{"key":"BF1001948_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","volume":"74","author":"EL Bravo","year":"1983","unstructured":"Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW et al. The changing clinical spectrum of primary aldosteronism. Am J Med 1983; 74: 641\u2013651.","journal-title":"Am J Med"},{"key":"BF1001948_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00026.2001","volume":"82","author":"K Kunzelmann","year":"2002","unstructured":"Kunzelmann K, Mall M . Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 2002; 82: 245\u2013289.","journal-title":"Physiol Rev"},{"key":"BF1001948_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42: 161\u2013165.","journal-title":"Hypertension"},{"key":"BF1001948_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","volume":"15","author":"E Rossi","year":"2002","unstructured":"Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F . High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 2002; 15: 896\u2013902.","journal-title":"Am J Hypertens"},{"key":"BF1001948_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/07435809209035402","volume":"18","author":"MS Gordon","year":"1992","unstructured":"Gordon MS, Williams GH, Hollenberg NK . Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade. Endocr Res 1992; 18: 115\u2013131.","journal-title":"Endocr Res"},{"key":"BF1001948_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.0954-6820.1981.tb11587.x","volume":"209","author":"P Manhem","year":"1981","unstructured":"Manhem P, Hokfelt B . Prolonged clonidine treatment: catecholamines, renin activity and aldosterone following exercise in hypertensives. Acta Med Scand 1981; 209: 253\u2013260.","journal-title":"Acta Med Scand"},{"key":"BF1001948_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/pgmj.75.882.235","volume":"75","author":"MJ Brown","year":"1999","unstructured":"Brown MJ, Hopper RV . Calcium-channel blockade can mask the diagnosis of Conn's syndrome. Postgrad Med J 1999; 75: 235\u2013236.","journal-title":"Postgrad Med J"},{"key":"BF1001948_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.jhh.1001605","volume":"17","author":"BF Zhou","year":"2003","unstructured":"Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003; 17: 623\u2013630.","journal-title":"J Hum Hypertens"},{"key":"BF1001948_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/07435808709035467","volume":"13","author":"GK Adler","year":"1987","unstructured":"Adler GK, Moore TJ, Hollenberg NK, Williams GH . Changes in adrenal responsiveness and potassium balance with shifts in sodium intake. Endocr Res 1987; 13: 419\u2013445.","journal-title":"Endocr Res"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001948.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001948","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001948.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:38:58Z","timestamp":1647549538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,17]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF1001948"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001948","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,17]]},"assertion":[{"value":"1 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}